These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9585021)

  • 1. What can we conclude from the randomized controlled trials of fecal occult blood test screening?
    Lang CA; Ransohoff DF
    Eur J Gastroenterol Hepatol; 1998 Mar; 10(3):199-204. PubMed ID: 9585021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood.
    Mandel JS; Church TR; Ederer F; Bond JH
    J Natl Cancer Inst; 1999 Mar; 91(5):434-7. PubMed ID: 10070942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled trial of the impact of intensive patient education on compliance with fecal occult blood testing.
    Stokamer CL; Tenner CT; Chaudhuri J; Vazquez E; Bini EJ
    J Gen Intern Med; 2005 Mar; 20(3):278-82. PubMed ID: 15836533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for colorectal cancer.
    Mandel JS
    Curr Opin Gen Surg; 1994; ():79-84. PubMed ID: 7584018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does fecal occult blood testing really reduce mortality? A reanalysis of systematic review data.
    Moayyedi P; Achkar E
    Am J Gastroenterol; 2006 Feb; 101(2):380-4. PubMed ID: 16454847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of continued mailed fecal tests in the patient-centered medical home: Year 3 of the Systems of Support to Increase Colon Cancer Screening and Follow-Up randomized trial.
    Green BB; Anderson ML; Chubak J; Fuller S; Meenan RT; Vernon SW
    Cancer; 2016 Jan; 122(2):312-21. PubMed ID: 26488332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Features of colorectal cancer with fecal-occult-blood tests--comparison with colorectal cancer with no screening].
    Takemasa I; Kikkawa N; Yasui M; Nishisho I; Fujitani K; Mishima H; Hasuike Y; Kobayashi K
    Gan To Kagaku Ryoho; 1998 Aug; 25(10):1514-8. PubMed ID: 9725042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy.
    Winawer SJ; Flehinger BJ; Schottenfeld D; Miller DG
    J Natl Cancer Inst; 1993 Aug; 85(16):1311-8. PubMed ID: 8340943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].
    Quintero E
    Gastroenterol Hepatol; 2009 Oct; 32(8):565-76. PubMed ID: 19577340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of colonoscopy in screening for colorectal cancer.
    Sonnenberg A; Delcò F; Inadomi JM
    Ann Intern Med; 2000 Oct; 133(8):573-84. PubMed ID: 11033584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal occult blood screening for colorectal cancer.
    Van Dam J; Bond JH; Sivak MV
    Arch Intern Med; 1995 Dec 11-25; 155(22):2389-402. PubMed ID: 7503597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for colorectal cancer with the fecal occult blood test: a background paper. American College of Physicians.
    Ransohoff DF; Lang CA
    Ann Intern Med; 1997 May; 126(10):811-22. PubMed ID: 9148658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal cancer: implications of mass screening for public health.
    Woodward A; Weller D
    Med J Aust; 1990 Jul; 153(2):81-2, 85-8. PubMed ID: 2288572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing.
    Helm JF; Russo MW; Biddle AK; Simpson KN; Ransohoff DF; Sandler RS
    Am J Gastroenterol; 2000 Nov; 95(11):3250-8. PubMed ID: 11095350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A national survey of primary care physicians' methods for screening for fecal occult blood.
    Nadel MR; Shapiro JA; Klabunde CN; Seeff LC; Uhler R; Smith RA; Ransohoff DF
    Ann Intern Med; 2005 Jan; 142(2):86-94. PubMed ID: 15657156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal occult blood screening for colorectal cancer. Is mortality reduced by chance selection for screening colonoscopy?
    Lang CA; Ransohoff DF
    JAMA; 1994 Apr; 271(13):1011-3. PubMed ID: 8139058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of screening for colorectal cancer in the general population.
    Frazier AL; Colditz GA; Fuchs CS; Kuntz KM
    JAMA; 2000 Oct; 284(15):1954-61. PubMed ID: 11035892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival of patients diagnosed with colorectal cancer through a television-advertised screening program.
    Slusser SO; Liberski SM; McGarrity TJ
    Am J Gastroenterol; 1996 Aug; 91(8):1563-6. PubMed ID: 8759662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update.
    Hewitson P; Glasziou P; Watson E; Towler B; Irwig L
    Am J Gastroenterol; 2008 Jun; 103(6):1541-9. PubMed ID: 18479499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Feasibility of colorectal cancer screening with fecal occult blood test distributed by public pharmacies].
    Pippa G; Ferrara M; Valle S; Diego B; Alessandra B; Apuzzo M; Bazuro ME; Tammaro G; Federici A
    Recenti Prog Med; 2009; 100(7-8):348-51. PubMed ID: 19725474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.